Help your patients control their gout

Study: 
Gout Self-management app

 

Overview:

This University of New South Wales (UNSW) research is led by Professor Ric Day and aims to evaluate the effectiveness of an innovative self-management mobile app, developed to support people with gout to achieve target serum urate concentrations. The research focuses predominantly on self-management, which means there is minimal burden on the practice. 

Why get involved?

  • Help your patients control their gout and achieve a better quality of life using innovative self-management support tools.

  • This activity has been accredited for 40 (Category 1) points in the RACGP QI & CPD Program for the 2017–19 triennium. It has also been accredited for 30 PRPD points in the ACRRM PDP for the 2017–19 triennium. Activities to gain points are flexible and easy to participate in. More information about the activities involved is available on request.

  • Participating practices will receive gift cards to the value of $300 and patients will receive $90 worth of gift cards for their participation.

Eligibility Criteria:

  • Practices must be in Australia. 

  • Patients must have had at least two attacks of gout in the past year, have access to a smartphone or tablet device connected to the internet and be receiving or eligible to receive urate-lowering therapy to prevent gout attacks.

What is required?

If you decide to take part in the research, the UNSW research team will
ask you to: 

  • identify, screen and recruit at least three patients with gout into the trial. Assistance is available to help you identify relevant patients 

  • review participating patients at least three times within one year (at the commencement of the trial, then after six and twelve months)  

  • consider participating in an optional interview with researchers from UNSW at the end of the study to tell them about your experiences with treating gout. 

How to get involved: 

Practice consent is required for you to participate in this research. To provide consent for NPS MedicineWise to pass on your contact details to the researchers, click here and send us the prefilled email. The researchers will then contact you directly. Alternatively, if you have any questions, please contact us on clinicaltrialassist@nps.org.au


Support for patients who are overweight and obese

Study:
HeLP-GP
(Health e-Literacy for Prevention in General Practice) 

 

Overview: 

This University of New South Wales (UNSW) research is led by Professor Mark Harris in collaboration with the University of Adelaide and partner organisations. It is a National Health and Medical Research Council (NHMRC)-funded trial that tests a combination of mobile health and telephone counseling resources for patients who are overweight and obese to improve their diet, physical activity and general health. 

Why get involved?

  • Help your patients control their weight and achieve a better quality of life using evidence-based support. 

  • Gain 40 (Category 1) points (RACGP Activity Number 114640) for participation in clinical audit activities. Category 2 CPD points (3 points) are also available for completion of online education modules.

  • Receive monetary reimbursement of $1,000 per practice.

  • Practice nurses associated with intervention practices will receive $40 for initial patient health checks and $20 for a 6-week follow-up visit.   

Eligibility Criteria:

Your practice is eligible if:

  • it uses either Medical Director, Medinet or Best Practice and associated billing software 

  • it has a practice nurse available to deliver the trial intervention

  • it is in a low socioeconomic area in one of the following PHNs:

    • NSW: Central and Eastern Sydney, South Western Sydney, Illawarra

    • SA: Adelaide

What is required?

Activities depend on whether your practice is randomised to the intervention or control arm. All practices, regardless of randomisation, participate in:     

  • an automated pre-baseline clinical audit of patients aged 40–74 years

  • a practice assessment profile and practitioner survey on management of patients who are overweight

  • identification of eligible patients.

In addition, intervention practices participate in:

  • staff training for practice nurses and GPs through education modules
    to support delivery of the intervention

  • funded delivery of a 40-minute health check by practice nurses to consenting patients

  • free access for patients participating in the research to support services including my snapp lifestyle app and Get Healthy telephone-based health coaching

  • a follow-up consultation with enrolled patients at 6 weeks (by practice nurses), 12 weeks and 12 months (by GPs).

Control practices will be asked to provide the usual clinical practice routinely offered to patients. Between 12 and 18 months, from the start of the study, control practices will have the opportunity to access my snapp and complete the online CPD training requirements. 

How to get involved: 

Practice consent is required for you to participate in the HeLP-GP research.  

To provide consent for NPS MedicineWise to pass on your contact details to the researchers, click here and send us the prefilled email. The researchers will then contact you directly.  

Alternatively, if you have any questions, please contact us on clinicaltrialassist@nps.org.au  


A new treatment approach to blood pressure management

Study: Quadruple UltrA-low-dose tReaTment for hypErTension (QUARTET)

Overview: 

The George Institute and the University of Sydney (in conjunction with the research centres detailed below) are conducting a multicentre, randomised double-blind controlled trial – the Quartet study. The research is investigating whether treatment with a combination of four blood pressure-lowering medicines in ultra-low dose will lower blood pressure more effectively, and with fewer side effects, compared with standard dose monotherapy as recommended in current guidelines for people with hypertension. 

Why get involved:

  • Help your patients control their blood pressure using a new treatment approach.

Eligibility Criteria:

There are no specific criteria for practices or GPs to be involved. 
The research is being conducted at the following centres:

  • NSW: Westmead Hospital, Royal North Shore Hospital,
    Castle Hill Medical Centre.

  • WA: Royal Perth Hospital, Curtin University.

  • VIC: Monash University.

  • TAS: University of Tasmania.

What is required? 

  • Referral of potential eligible patients to researchers in your area. 

How to get involved: 

To provide consent for NPS MedicineWise to pass on your contact details to the researchers, click here and send us the prefilled email. The researchers will then contact you directly. Alternatively, if you have any questions, please contact us on clinicaltrialassist@nps.org.au